about
Update on the safety of second generation antipsychotics in youths: a call for collaboration among paediatricians and child psychiatristsA nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patientsIndomethacin potentiates acetylcholine-induced vasodilation by increasing free radical productionPattern of statin use in southern italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment?Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination.Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy.Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy.Drug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase.Effects of sildenafil on the gastrocnemius and cardiac muscles of rats in a model of prolonged moderate exercise training.Hypoglycemia, polycythemia and hyponatremia in a newborn exposed to nebivolol during pregnancy.Inflammatory events in a vascular remodeling model induced by surgical injury to the rat carotid artery.Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011.Basal supplementation of insulin lispro protamine suspension versus insulin glargine and detemir for type 2 diabetes: meta-analysis of randomized controlled trialsDipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin.Pharmacovigilance in Italy: An overviewBacterial lysates as a potentially effective approach in preventing acute exacerbation of COPD.Humalog (lispro) for type 2 diabetes.Should we abandon statins in the prevention of bone fractures?Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis.Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis.Metabolic syndrome and endometrial cancer: a meta-analysis.Metformin in lung cancer: rationale for a combination therapy.Metabolic syndrome and cancer: holistic or reductionist?Baseline glycemic parameters predict the hemoglobin A1c response to DPP-4 inhibitors : meta-regression analysis of 78 randomized controlled trials with 20,053 patients.Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network.Rational use of antibiotics for the management of children's respiratory tract infections in the ambulatory setting: an evidence-based consensus by the Italian Society of Preventive and Social Pediatrics.The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?Type III or allosteric kinase inhibitors for the treatment of non-small cell lung cancer.Glycaemic durability with dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of long-term randomised controlled trials.Guanfacine for attention deficit and hyperactivity disorder in pediatrics: a systematic review and meta-analysis.Can vaccines interact with drug metabolism?Immunogenicity of meningococcal quadrivalent (serogroup A, C, W135 and Y) tetanus toxoid conjugate vaccine: systematic review and meta-analysis.Fluticasone furoate and vilanterol inhalation powder for the treatment of chronic obstructive pulmonary disease.Intraperitoneal oxygen/ozone treatment decreases the formation of experimental postsurgical peritoneal adhesions and the levels/activity of the local ubiquitin-proteasome system.Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF).The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy.Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases.Hyperglycemia in streptozotocin-induced diabetes leads to persistent inflammation and tissue damage following uveitis due to reduced levels of ciliary body heme oxygenase-1.Modulation of RAAS-natriuretic peptides in the treatment of HF: Old guys and newcomers.
P50
Q26747123-90B10887-805A-4298-A892-F09AAD32C6F4Q26995462-DEA78567-FDD7-4B91-967C-935BF3CB8FF4Q28209224-04C0EC4F-9DA9-4FA6-881D-3B4C02B8CEB5Q28541300-B1D2A663-7907-43BD-9A04-301BF715E029Q30400768-AD14D6B3-725B-4086-B662-DCDE18C88DC6Q30988486-02B33FD4-48E3-41CB-958E-3F2BE08032EEQ31060620-10656B3E-46E0-44B2-B25C-0837D398DD80Q33387447-A6FB554E-C36C-453E-A956-277E513A8025Q34381361-2EC38060-ADC2-4C1F-85A1-C8E037EFFEF8Q34905015-61FE7BCB-A21A-4977-A666-DDEECDE69206Q35056331-96B71727-F5A1-4BF0-9E1D-B1FAFE1C774AQ35098614-FB7DEADD-4B3C-419D-82AE-692FFBA8ABDDQ35684841-A042E854-F179-4BED-90DA-440105F226C4Q36426817-25A79AC7-A1DF-4189-933A-32D511DD8C99Q37195882-C2F12E1A-113A-4DCB-BC89-9803FAEF9531Q37369630-A0BC2FDF-60CB-4EDB-B73B-270351C16423Q37988186-42FA73BB-38AE-4322-A2FD-E530A8E337E1Q38050151-6C0C7CBA-D291-420E-BDAF-9108AF6C4CD5Q38092753-57B154ED-49E3-44DC-8AD8-33E6D5D3B8F3Q38094977-0FDA970A-9EB5-4570-96E5-94B9C1D1CFF4Q38097664-307F7AF8-85DC-4840-AD66-D83FFBCB7FBDQ38103791-56BD34AD-ED87-4DD5-9ABD-F260239C59C9Q38128357-6ECC9156-D120-4651-9F6D-F377593BD302Q38142797-111AFD81-1528-4601-B4A9-00A2119FEFF3Q38163894-43254C36-2928-4EC4-B476-44FF08D65841Q38180415-99B7D27D-F946-4BBB-9572-6F0CADC6D1ADQ38199213-09CE269C-6562-4B6B-9212-2773AAED5B8FQ38199712-24B1972F-D896-4A47-BD31-E2D319AF8071Q38199737-B2536485-E84B-4F74-B364-51A2CD883FFCQ38219234-2658E38B-A03C-4512-8EA0-57B52B38F859Q38243242-FCF9EFE2-2DF3-4154-88C1-829DF1E52CD4Q38254557-74167D7D-2EC2-46F2-A669-87D5E147CB9BQ38275208-7D4E3931-FEF6-4F84-ACDB-89524AB89C53Q38284373-01D0F007-6FC5-480C-9EE8-62EE7B5B8E68Q38587740-1577C223-61F8-4B09-A086-2E1BDF4C8802Q38592650-A261393E-B39C-4C5F-8F5F-65110FF989F7Q38605987-F4F0782B-9491-409C-AFE4-B3D4B3E01587Q38731788-07E1C5D5-C8FA-4B6A-93BF-239C49114E41Q38787591-0CB21646-2A26-4C54-B297-ADF6C9E14BEBQ38807538-201D9E7E-734D-4E28-B002-A7DBF08DC23A
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Annalisa Capuano
@ast
Annalisa Capuano
@en
Annalisa Capuano
@es
Annalisa Capuano
@nl
Annalisa Capuano
@sl
type
label
Annalisa Capuano
@ast
Annalisa Capuano
@en
Annalisa Capuano
@es
Annalisa Capuano
@nl
Annalisa Capuano
@sl
prefLabel
Annalisa Capuano
@ast
Annalisa Capuano
@en
Annalisa Capuano
@es
Annalisa Capuano
@nl
Annalisa Capuano
@sl
P106
P1153
7003885772
P21
P31
P496
0000-0002-8653-2408